Sign In
Buy GNMK
$24.04
+0 (+0%)
At Close: May 27, 2022
Recap: GenMark Diagnostics Q2 Earnings
09:20pm, Tuesday, 04'th Aug 2020
Shares of GenMark Diagnostics (NASDAQ:GNMK) moved lower by 6.81% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 69.57% over the past year to
GenMark Diagnostics Reports Second Quarter 2020 Results
08:05pm, Tuesday, 04'th Aug 2020
CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial
The Global Influenza Diagnostics Market will grow by $ 1.32 bn during 2020-2024
GenMark Diagnostics, Inc Up 258% This Year, Conditions Ideal for More
11:34am, Monday, 03'rd Aug 2020
GenMark Diagnostics, Inc (NASDAQ:GNMK), a key player in the molecular diagnostic solutions space, is set for stronger growth as the demand for diagnostic screening testing rise while its price decline
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
08:05pm, Wednesday, 29'th Jul 2020
CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the c
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Why A Covid-19 Vaccine Won't Halt Feverish Demand For Coronavirus Tests
02:15pm, Friday, 24'th Jul 2020
You'd think that, as biopharma companies close in on an effective vaccine to do battle against Covid-19, the days of widespread coronavirus tests are numbered. Not so fast, analysts say.
Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?
04:22pm, Wednesday, 22'nd Jul 2020
Unfortunately, investing is risky - companies can and do go bankrupt. But if you pick the right stock, you can make a...
Has GenMark Diagnostics (GNMK) Outpaced Other Medical Stocks This Year?
03:30pm, Wednesday, 22'nd Jul 2020
Is (GNMK) Outperforming Other Medical Stocks This Year?
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
08:05pm, Tuesday, 21'st Jul 2020
CARLSBAD, Calif., July 21, 2020 -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close.
Biodesix Appoints Jean Franchi and Hany Massarany to Board of Directors
12:00am, Monday, 20'th Jul 2020
Biodesix, Inc. a leader in lung cancer diagnostics, today announced the appointment of Jean Franchi and Hany Massarany to the company’s board of direc
2 Companies In The Fast-Growing Market For Molecular Diagnostics And Genetic Testing
03:21pm, Tuesday, 14'th Jul 2020
Mike Cintolo is a leading growth stock expert and is the editor of Cabot Top Ten Trader. Highlights two companies (GNMK and NVTA) in the fast-growing market for molecular diagnostics and genetic testi
GenMark's Shares March Higher, Can It Continue?
10:56am, Tuesday, 14'th Jul 2020
As of late, it has definitely been a great time to be an investor in GenMark Diagnostics.
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?
01:54am, Friday, 10'th Jul 2020
The coronavirus has had a negative impact on most but as luck would have it, some companies have benefited from the viral outbreak. Along with those catering to the stay at home climate, healthcare co
